The Reliable, Automatic Classification of Neonates in First-Tier MALDI-MS Screening for Sickle Cell Disease
Previous research has shown that a MALDI-MS technique can be used to screen for sickle cell disease (SCD), and that a system combining automated sample preparation, MALDI-MS analysis and classification software is a relevant approach for first-line, high-throughput SCD screening. In order to achieve...
Main Authors: | Marven El Osta, Pierre Naubourg, Olivier Grunewald, Gilles Renom, Patrick Ducoroy, Jean Marc Périni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/5/3/31 |
Similar Items
-
A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform
by: Pierre Naubourg, et al.
Published: (2019-01-01) -
Immuno-MALDI-MS in Human Plasma and On-Chip Biomarker Characterizations at the Femtomole Level
by: Wilfrid Boireau, et al.
Published: (2012-11-01) -
Identification of Sickle Cell Anemia Using Deep Neural Networks
by: Sagar Yeruva, et al.
Published: (2021-04-01) -
Anesthetic management of a patient with sickle β+ thalassemia
by: Saswata Bharati, et al.
Published: (2011-01-01) -
Manifestations of HbSE sickle cell disease: a systematic review
by: Ibrahim Khamees, et al.
Published: (2021-06-01)